TR200101929T2 - Geliştirilmiş kararlılığa sahip bileşimler. - Google Patents
Geliştirilmiş kararlılığa sahip bileşimler.Info
- Publication number
- TR200101929T2 TR200101929T2 TR2001/01929T TR200101929T TR200101929T2 TR 200101929 T2 TR200101929 T2 TR 200101929T2 TR 2001/01929 T TR2001/01929 T TR 2001/01929T TR 200101929 T TR200101929 T TR 200101929T TR 200101929 T2 TR200101929 T2 TR 200101929T2
- Authority
- TR
- Turkey
- Prior art keywords
- compositions
- liquid
- improved stability
- active substances
- pharmaceutically active
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000007788 liquid Substances 0.000 abstract 4
- 239000013543 active substance Substances 0.000 abstract 2
- 239000002775 capsule Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Bulus, farmasötik olarak etkin maddelerin vücuda verilmesinin gelistirildigi bilesimlerle ilgilidir. Bu bilesimler farmasötik olarak etkin maddeleri çözücü içinde içermektedirler. Bu bilesimler, agiz içine konulan ve neticede yutulan sivi iksirler seklini alabilmekte veya sivi-dolgulu damlalar, ölçümlü sivi dozlama düzenekleri, atomizörler ve sivi-salan, yenilebilir kapsüller araciligiyla uygulanabilmektedir.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11537899P | 1999-01-11 | 1999-01-11 | |
US15653999P | 1999-09-29 | 1999-09-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200101929T2 true TR200101929T2 (tr) | 2001-12-21 |
Family
ID=26813132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/01929T TR200101929T2 (tr) | 1999-01-11 | 2000-01-10 | Geliştirilmiş kararlılığa sahip bileşimler. |
Country Status (16)
Country | Link |
---|---|
US (1) | US20020086878A1 (tr) |
EP (1) | EP1143973A2 (tr) |
JP (1) | JP2002534462A (tr) |
KR (1) | KR20010093256A (tr) |
CN (1) | CN1346270A (tr) |
AU (1) | AU3344900A (tr) |
BR (1) | BR0007428A (tr) |
CA (1) | CA2360358A1 (tr) |
CO (1) | CO5430216A1 (tr) |
CZ (1) | CZ20012493A3 (tr) |
HU (1) | HUP0105279A3 (tr) |
ID (1) | ID30508A (tr) |
NO (1) | NO20013440L (tr) |
PE (1) | PE20001397A1 (tr) |
TR (1) | TR200101929T2 (tr) |
WO (1) | WO2000041692A2 (tr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2475376C (en) | 2002-02-08 | 2008-07-22 | The Procter & Gamble Company | Child resistant sachet |
US20040028622A1 (en) * | 2002-08-12 | 2004-02-12 | Michael Gurin | Multifunctional flavor systems and method of use |
EP1575569B1 (en) | 2002-12-13 | 2010-09-29 | Durect Corporation | Oral drug delivery system comprising high viscosity liquid carrier materials |
JP4542743B2 (ja) * | 2002-12-26 | 2010-09-15 | Kdl株式会社 | ピリドン誘導体の溶液状医薬組成物 |
US20070048424A1 (en) * | 2005-09-01 | 2007-03-01 | Moza Ashok K | Liquid composition of 2-Isopropyl-N,2,3-trimethylbutyramide and N-Ethyl-p-menthane-3-carboxamide, its preparation method and its applications as a cooling agent and flavor enhancer |
US20070059417A1 (en) * | 2005-09-15 | 2007-03-15 | Moza Ashok K | Cooling agents as flavor and saltiness enhancers |
FR2906140B1 (fr) * | 2006-09-22 | 2008-12-05 | Philippe Perovitch | Forme galenique pour l'administration par voie trans-muqueuse de principes actifs |
FR2910317B1 (fr) | 2006-12-21 | 2009-02-13 | Philippe Perovitch | Forme galenique pour l'administration par voie transmuqueuse de paracetamol |
US8415401B2 (en) | 2007-12-06 | 2013-04-09 | Durect Corporation | Oral pharmaceutical dosage forms |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
US8518439B2 (en) * | 2008-12-03 | 2013-08-27 | Novartis Ag | Liquid therapeutic composition |
CN105120659A (zh) | 2013-03-15 | 2015-12-02 | 度瑞公司 | 用于降低溶解可变性的具有流变改性剂的组合物 |
WO2018183203A1 (en) * | 2017-03-27 | 2018-10-04 | DXM Pharmaceutical, Inc. | Packaged multi-dose liquid drug formulation |
US11234897B2 (en) | 2017-03-27 | 2022-02-01 | DXM Pharmaceutical, Inc. | Packaged multi-dose liquid dextromethorphan hydrobromide formulation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5100898A (en) * | 1990-01-25 | 1992-03-31 | Richardson-Vicks Inc. | Antitussive liquid compositions containing dyclonine |
PL315635A1 (en) * | 1994-01-24 | 1996-11-25 | Procter & Gamble | Method of solubilising hardly pharmaceutically active substances |
US5510389A (en) * | 1994-03-02 | 1996-04-23 | The Procter & Gamble Company | Concentrated acetaminophen solution compositions |
US5616621A (en) * | 1995-01-30 | 1997-04-01 | American Home Products Corporation | Taste masking liquids |
-
1999
- 1999-12-20 US US09/467,334 patent/US20020086878A1/en not_active Abandoned
-
2000
- 2000-01-10 CN CN00802686A patent/CN1346270A/zh active Pending
- 2000-01-10 HU HU0105279A patent/HUP0105279A3/hu unknown
- 2000-01-10 JP JP2000593303A patent/JP2002534462A/ja not_active Abandoned
- 2000-01-10 AU AU33449/00A patent/AU3344900A/en not_active Abandoned
- 2000-01-10 WO PCT/US2000/000574 patent/WO2000041692A2/en not_active Application Discontinuation
- 2000-01-10 PE PE2000000018A patent/PE20001397A1/es not_active Application Discontinuation
- 2000-01-10 CZ CZ20012493A patent/CZ20012493A3/cs unknown
- 2000-01-10 EP EP00911569A patent/EP1143973A2/en not_active Withdrawn
- 2000-01-10 TR TR2001/01929T patent/TR200101929T2/tr unknown
- 2000-01-10 BR BR0007428-4A patent/BR0007428A/pt not_active IP Right Cessation
- 2000-01-10 CA CA002360358A patent/CA2360358A1/en not_active Abandoned
- 2000-01-10 KR KR1020017008797A patent/KR20010093256A/ko not_active Application Discontinuation
- 2000-01-10 ID IDW00200101509A patent/ID30508A/id unknown
- 2000-01-11 CO CO00001050A patent/CO5430216A1/es not_active Application Discontinuation
-
2001
- 2001-07-11 NO NO20013440A patent/NO20013440L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CZ20012493A3 (cs) | 2001-11-14 |
WO2000041692A3 (en) | 2000-11-30 |
JP2002534462A (ja) | 2002-10-15 |
US20020086878A1 (en) | 2002-07-04 |
HUP0105279A3 (en) | 2003-05-28 |
AU3344900A (en) | 2000-08-01 |
KR20010093256A (ko) | 2001-10-27 |
PE20001397A1 (es) | 2000-12-21 |
BR0007428A (pt) | 2002-10-15 |
WO2000041692A2 (en) | 2000-07-20 |
HUP0105279A2 (hu) | 2002-05-29 |
CO5430216A1 (es) | 2004-06-01 |
NO20013440L (no) | 2001-09-11 |
EP1143973A2 (en) | 2001-10-17 |
NO20013440D0 (no) | 2001-07-11 |
CA2360358A1 (en) | 2000-07-20 |
CN1346270A (zh) | 2002-04-24 |
ID30508A (id) | 2001-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200101927T2 (tr) | Etkin maddelerin geliştirilmiş bir şekilde verilmesini sağlayan bileşimler. | |
TR200101929T2 (tr) | Geliştirilmiş kararlılığa sahip bileşimler. | |
BR0213143A (pt) | Composições lìquidas para administração oral contendo guaifenesina e um copolìmero de bloco polioxialquileno | |
HUP0202797A2 (hu) | Javított stabilitású készítmények | |
WO2007040469A3 (en) | Chloroquine coupled compositions and methods for their synthesis | |
WO2004054542A3 (en) | Oral drug delivery system comprising high viscosity liquid carrier materials | |
UA42061C2 (uk) | Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса | |
NO20030897D0 (no) | Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer | |
AR022930A2 (es) | MICROCAPSULAS, DE TIPO RESERVORIO, QUE CONTIENEN POR LO MENOS UN PRINCIPIO ACTIVO MEDICAMENTOSO Y/O NUTRITIVO (PA) CON EXCLUSION DEL ACIDO ACETILSALICILICO (ASA), DESTINADAS A LA ADMINISTRACION POR VIA ORAL, SU UTILIZACIoN Y FORMA FARMACEUTICA QUE COMPRENDE A DICHAS MICROCAPSULAS. | |
TR200101928T2 (tr) | Geliştirilmiş kararlılığa sahip bileşimler | |
SE0003449D0 (sv) | Anticancer compositions | |
DE60312523D1 (de) | Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit | |
WO2009029958A3 (en) | Implantable delivery device | |
ATE202931T1 (de) | Taxanderivate enthaltende arzneizubereitungen | |
DE602008006700D1 (tr) | ||
BR0111678A (pt) | Composições medicinais contendo derivados de propenona | |
MXPA04004907A (es) | Composiciones de acetaminofen. | |
TW200509985A (en) | Drug delivery system for sub-Tenon administration of fine particles | |
ATE314109T1 (de) | Dosierbehälter für pulverförmige medikamente | |
ATE256134T1 (de) | Sulfatierte phosphatidylinositole, ihre herstellung und verwendung | |
NZ596881A (en) | Phentermine liquid dosage form | |
TH63200A (th) | สูตรผสมเอนทีคาเวอร์ชนิดของเหลวที่มีขนาดการใช้ยาต่ำ และการใช้ | |
MY133368A (en) | Process for preparing pharmaceutical compositions for use with soft gelatin formulations | |
RU94022194A (ru) | Основа лекарственного средства | |
UA34406A (uk) | Засіб для лікування розсіяного склерозу, спосіб лікування з його використанням та фармацевтична упаковка |